The US Supreme Court decision in US v Arthrex (2021) may have been the tip of the iceberg when it comes to challenges to proceedings before the Patent Trial and Appeal Board (PTAB).
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
22 June 2021 In a decision highly anticipated by patent owners, the US Supreme Court has delivered its final ruling in US v Arthrex—a fractured opinion that lawyers say leaves burning questions around its political implications.
2 March 2021 The US Supreme Court heard the first arguments for The United States v Arthrex on Monday, in a case that could shape the future of patent litigation in the US.
25 April 2022 The US Patent and Trademark Office is seeking input to help formalise the process that allows the director to review decisions handed down by the Patent Trial and Appeal Board.